R-spondin-3



R-spondin-3

Q1QQ1N2NN2A3AA3S4SS4R5RR5G6GG6R7RR7R8RR8Q9QQ9R10RR10R11RR11M12MM12H13HH13P14PP14N15NN15V16VV16S17SS17Q18QQ18G19GG19C20CC20Q21QQ21G22GG22G23GG23C24CC24A25AA25T26TT26C27CC27S28SS28D29DD29Y30YY30N31NN31G32GG32C33CC33L34LL34S35SS35C36CC36K37KK37P38PP38R39RR39L40LL40F41FF41F42FF42A43AA43L44LL44E45EE45R46RR46I47II47... and 204 more residue(s)...... and 204 more residue(s)

SMILES None
InChIKey None
Sequence QNASRGRRQRRMHPNVSQGCQGGCATCSDYNGCLSCKPRLFFALERIGMKQIGVCLSSCPSGYYGTRYPDINKCTKCKADCDTCFNKNFCTKCKSGFYLHLGKCLDNCPEGLEANNHTMECVSIVHCEVSEWNPWSPCTKKGKTCGFKRGTETRVREIIQHPSAKGNLCPPTNETRKCTVQRKKCQKGERGKKGRERKRKKPNKGESKEAIPDSKSLESSKEIPEQRENKQQQKKRKVQDKQKSVSVSTVH

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

R-spondin-3

Q1QQ1N2NN2A3AA3S4SS4R5RR5G6GG6R7RR7R8RR8Q9QQ9R10RR10R11RR11M12MM12H13HH13P14PP14N15NN15V16VV16S17SS17Q18QQ18G19GG19C20CC20Q21QQ21G22GG22G23GG23C24CC24A25AA25T26TT26C27CC27S28SS28D29DD29Y30YY30N31NN31G32GG32C33CC33L34LL34S35SS35C36CC36K37KK37P38PP38R39RR39L40LL40F41FF41F42FF42A43AA43L44LL44E45EE45R46RR46I47II47... and 204 more residue(s)...... and 204 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.